Market expects limited future growth for Chongqing Zhifei Bi...
Market expects limited future growth for Chongqing Zhifei Biological Products, contributing to its low P/E ratio. The inferior earnings outlook forms a barrier for the share price.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more